Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 208,812 | 288,028 | 169,498 | 111,792 | 58,321 |
| Marketable Securities | 894,838 | 398,535 | 58,088 | 79,454 | 173,345 |
| Receivables | 69,929 | 55,538 | 67,907 | 40,394 | 24,929 |
| Inventories | 18,697 | 19,285 | 16,117 | 10,754 | N/A |
| TOTAL | $1,231,745 | $779,284 | $320,857 | $249,063 | $261,286 |
| Non-Current Assets | |||||
| PPE Net | 33,831 | 21,549 | 12,694 | 8,376 | 7,429 |
| Intangibles | 797,669 | 792,841 | 783,372 | 132,993 | 0 |
| Other Non-Current Assets | 145,033 | 30,108 | 2,299 | 1,221 | 630 |
| TOTAL | $976,533 | $844,498 | $798,365 | $142,590 | $8,059 |
| Total Assets | $2,208,278 | $1,623,782 | $1,119,222 | $391,653 | $269,345 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,023 | 20,000 | 11,667 | N/A | N/A |
| Accounts payable and accrued liabilities | 242,168 | 199,276 | 147,599 | 76,446 | 48,759 |
| Other current liabilities | 1,250 | 3,186 | 3,814 | 1,665 | 865 |
| TOTAL | $277,333 | $235,857 | $166,796 | $82,048 | $49,624 |
| Non-Current Liabilities | |||||
| Long Term Debt | 967,884 | 293,859 | 141,347 | 144,971 | 98,216 |
| Deferred Revenues | 4,151 | 8,242 | 3,716 | 3,937 | N/A |
| Other Non-Current Liabilities | 321,291 | 365,459 | 310,298 | 243 | 335 |
| TOTAL | $1,448,963 | $793,595 | $601,699 | $153,168 | $100,138 |
| Total Liabilities | $1,726,296 | $1,029,452 | $768,495 | $235,216 | $149,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,322 | 62,633 | 58,402 | 41,796 | 34,556 |
| Common Shares | 70 | 62 | 51 | 42 | 34 |
| Retained earnings | -1,628,877 | -1,190,499 | -938,923 | -814,108 | -735,108 |
| Other shareholders' equity | -60,957 | -10,584 | 1,462 | 3,969 | -1,485 |
| TOTAL | $481,982 | $594,330 | $350,727 | $156,437 | $119,583 |
| Total Liabilities And Equity | $2,208,278 | $1,623,782 | $1,119,222 | $391,653 | $269,345 |